K-pop

AnTeam to Open at the Grammy Museum… Making a Full-Scale Push into the U.S. Market

Appeared on 'Global Spin Live'… Hosted the stage and talk segments Expanding Reach Beyond Asia to Music Fans in the U.S.

YUN GI BACK
2026-07-17 11:38:01
[Edaily Starin YUN GI BACK Reporter] The group &TEAM is set to take the stage at the Grammy Museum in the U.S., further expanding its global reach. By broadening its connection with the U.S. music market beyond Asia, the group appears to be strengthening its presence as “HYBE’s first global group.”
(Photo courtesy of YX Labels)

According to their agency, YX Labels, on the 17th, &TEAM will appear at “Global Spin Live,” taking place on August 12 (local time) at the Grammy Museum in Los Angeles, USA.
“Global Spin Live” is a flagship program hosted by the Grammy Museum that invites notable artists from around the world to present performances and talks. On the day of the event, ANTEAM will not only showcase a performance on stage but also discuss their music, activities, and future plans with host Emily Mei.
The Grammy Museum has also taken notice of ANTEAM. Through its official social media channels, the museum introduced the group, stating, “ANTEAM is a group born from the vision of nine individuals with distinct personalities coming together as one team to connect diverse worlds,” adding, “They are a group ready to captivate audiences worldwide with their unique energy and passion.”
This appearance is a symbolic step demonstrating ANTEAM’s global expansion. Having started their activities in Japan, ANTEAM has expanded their fanbase primarily in Korea and Asia, and is currently on an Asian tour visiting 14 cities. With the addition of their performance at the Grammy Museum, they are set to significantly broaden their reach among American music fans.
N.Team will release their second Korean mini-album, *Mark on Me*, on September 8 and continue their promotional activities both domestically and internationally.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02